Quva Pharma, Inc.
Sugar Land, TX
- UEI
- MUABDCZXMLG4
- CAGE
- 7VLA4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3 Sugar Creek Center Blvd #250, Sugar Land, TX 77478, USA
- Website
- quvapharma.com
- Founded
- 2015
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Outsourcing pcas and epidurals for patients care from quva pharma, INC. | Office of Logisitics and Acquisition Operations | $110,000 | |
| Pharmaceuticals quva pharma, INC.:1327585 [25-000116] | NIH Clinical Center | $100,000 | |
| IV medications quva pharma, INC.:1327585 [25-000665] | NIH Clinical Center | $25,000 | |
| Outsourcing pcas and epidurals | NIH Clinical Center | $250,000 | |
| Quva pharma, INC.:1327585 [23-000790] sterile compounded products | NIH Clinical Center | $60,000 |
About Quva Pharma, Inc.
Quva Pharma, Inc. is a for-profit corporate entity registered in SAM.gov since May 2017, located in Sugar Land, Texas, that specializes in providing sterile compounded pharmaceutical products to federal healthcare agencies. The company operates as a 503B outsourcing facility focused on delivering specialized pharmaceutical preparations, particularly in the domains of pain management and clinical research support. Its primary expertise lies in producing sterile intravenous medications, patient-controlled analgesia systems, and epidural products designed for complex medical treatment environments.
Over the past several years, Quva Pharma, Inc. has consistently provided pharmaceutical services primarily to the National Institutes of Health (NIH) Clinical Center through multiple federal contract awards. These contracts have ranged from $25,000 to $250,000 and have consistently focused on delivering specialized sterile pharmaceutical products, including patient-controlled analgesia systems (PCACs), epidural products, and other critical medical preparations. The company has demonstrated capabilities in supplying sophisticated medical compounds to federal healthcare facilities, with contracts previously involving the Department of Veterans Affairs, Defense Health Agency, and Department of the Army Medical Command. None of their historical contract awards have included specific set-aside designations, indicating they have competed in full and open competition.
Quva Pharma, Inc. has secured a single-award indefinite delivery contract (IDV) with the NIH Clinical Center, effective through September 30, 2025, with a ceiling value of $250,000. This IDV allows the company to provide non-patient-specific sterile compounded pharmaceutical products on an as-needed basis. The contract was awarded through a sole-source acquisition, recognizing Quva Pharma's unique capability to supply specialized compounded pharmaceutical products. The IDV encompasses the provision of sterile intravenous preparations, patient-controlled analgesia systems, and epidural products, supporting the NIH Clinical Center's pain management initiatives and clinical research needs. This contract mechanism enables the NIH to procure critical pharmaceutical products efficiently and directly from a trusted, specialized provider.
Quick answers
What is Quva Pharma, Inc.'s UEI?
Quva Pharma, Inc.'s Unique Entity ID (UEI) in SAM.gov is MUABDCZXMLG4.
What is Quva Pharma, Inc.'s CAGE code?
Quva Pharma, Inc.'s CAGE code is 7VLA4.
What is Quva Pharma, Inc.'s primary NAICS code?
Quva Pharma, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Quva Pharma, Inc. located?
Quva Pharma, Inc.'s physical address in SAM.gov is 3 Sugar Creek Center Blvd #250, Sugar Land, TX 77478, USA.
Is Quva Pharma, Inc. registered in SAM.gov?
Yes. Quva Pharma, Inc.'s SAM.gov registration is active through November 4, 2026.
What is Quva Pharma, Inc.'s most recent federal award?
Quva Pharma, Inc.'s most recent federal contract award is Outsourcing pcas and epidurals for patients care from quva pharma, INC (75N98026P00592), from Office of Logisitics and Acquisition Operations, on May 26, 2026.
On GovTribe
See Quva Pharma, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors